New radiolabeled CCK-8 analogues [Tc-99m-GH-CCK-8 and Tc-99m-DTPA-CCK-8]: preparation and biodistribution studies in rats and rabbits

Citation
T. Ertay et al., New radiolabeled CCK-8 analogues [Tc-99m-GH-CCK-8 and Tc-99m-DTPA-CCK-8]: preparation and biodistribution studies in rats and rabbits, NUCL MED BI, 28(6), 2001, pp. 667-678
Citations number
31
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
NUCLEAR MEDICINE AND BIOLOGY
ISSN journal
09698051 → ACNP
Volume
28
Issue
6
Year of publication
2001
Pages
667 - 678
Database
ISI
SICI code
0969-8051(200108)28:6<667:NRCA[A>2.0.ZU;2-5
Abstract
The aim of this study is to label CCK-8 with Tc-99m and to investigate its radiopharmaceutical potential. CCK-8 was labeled with Tc-99m using GH and D TPA as bifunctional chelating agents. Labeling efficiency was higher than 9 9%. Complex was stable more than 5 hours at room temperature. 37 MBq Tc-99m -GH-CCK-8 or Tc-99m-DTPA-CCK-8 was administered intravenously to rabbits fo r biodistribution experiments. Dynamic and static images were obtained from anterior projection using a Camstar XC/T gamma camera. For quantitative ev aluation, regions of interest were drawn on organs and time-activity curves were generated. The highest accumulation occurred in brain within 10 and 3 0 minutes after injection. Renal and hepatobiliary excretion were observed. Brain distribution studies in rats showed the highest activity was in hypo thalamus. Results demonstrated that Tc-99m-GH-CCK-8 and Tc-99m-DTPA-CCK-8 a nalogs may be a useful new class of receptor-binding peptides for diagnosis and therapy of brain diseases related with CCK-B receptor-expressing tumor s. (C) 2001 Elsevier Science Inc. All rights reserved.